Evaluation of the Performance of Non-molded Soft Contact Lenses
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00371787 |
|
Recruitment Status :
Completed
First Posted : September 4, 2006
Results First Posted : December 13, 2010
Last Update Posted : January 10, 2011
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Ametropia | Device: Soft contact lens | Phase 3 |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 38 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Evaluation of the Performance of Non-molded Soft Contact Lenses |
| Study Start Date : | August 2006 |
| Actual Primary Completion Date : | December 2007 |
| Actual Study Completion Date : | December 2007 |
| Arm | Intervention/treatment |
|---|---|
| Experimental: soft contact lens |
Device: Soft contact lens
Soft contact lens
Other Name: Custom O2Optix |
|
No Intervention: non-lens wear
control group
|
- Visual Acuity [ Time Frame: baseline ]level of vision measured using high contrast acuity chart, higher (more positive)logMAR indicates worse vision.
- Visual Acuity [ Time Frame: 9 month ]level of vision measured using high contrast acuity chart, higher (more positive)logMAR indicates worse vision.
- Neovascularisation [ Time Frame: baseline ]length of the blood vessels entering the superior cornea, higher number means longer blood vessel penetration.
- Neovascularization [ Time Frame: 9 month ]length of the blood vessels entering the superior cornea, higher number means longer blood vessel penetration.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 17 Years and older (Child, Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Male or female, good health, age >17yrs, able to wear contact lenses as primary vision correction, able to see well and achieve good fit with study lens, has understood & signed consent form.
Exclusion Criteria:
- Has active ocular disease, uses topical eye medication, wears gas permeable/silicone hydrogel /overnight wear contact lenses, is a participant in another clinical study, is deemed unsuitable for soft contact lens wear.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00371787
| Canada, Ontario | |
| Centre for Contact Lens Research, University of Waterloo, | |
| Waterloo, Ontario, Canada, N2L 3G1 | |
| Principal Investigator: | Desmond Fonn | Centre for Contact Lens Research |
| Responsible Party: | Craig Woods, Research Manager, CCLR |
| ClinicalTrials.gov Identifier: | NCT00371787 |
| Other Study ID Numbers: |
P/240/06/CV |
| First Posted: | September 4, 2006 Key Record Dates |
| Results First Posted: | December 13, 2010 |
| Last Update Posted: | January 10, 2011 |
| Last Verified: | January 2011 |
|
Refractive Errors Eye Diseases |

